← Open Payments lookup

MARK HOLLINGSWORTH: Open Payments

NPI 1871787549 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,245 in 115 payments from 21 companies in 2025. Trend: 2023 $1,319 · 2024 $1,509 · 2025 $2,245

Food & beverage: $2,245
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP16$458
ABBVIE INC.17$239
Corcept Therapeutics11$237
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$188
GlaxoSmithKline, LLC.11$176
Vanda Pharmaceuticals Inc.7$142
Lilly USA, LLC10$136
Novo Nordisk Inc7$125
Bayer Healthcare Pharmaceuticals Inc.4$97
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$93

Products named: BREZTRI, Korlym, CAPLYTA, TRELEGY ELLIPTA, VRAYLAR, MOUNJARO, HETLIOZ, Kerendia.

Industry payments across NC — which companies pay providers there.